Avita Medical is working with leading researchers and institutions in the field  of regenerative medicine and has more than 60 papers published in peer reviewed journals. Below is a selection of publications, to download the full bibliography please click here.

REPIGMENTATION: Treatment of vitiligo lesions by ReNovaCell® vs conventional melanocyte-keratinocyte transplantation(MKT): a pilot study.

Within-subject comparative study (n=5, MKT vs RES™). Comparable pigmentation was observed between RES™ and MKT, but without specialised laboratory facilities.

REPIGMENTATION: Evaluation for performance of ReNovaCell® for repigmentation.

RES™+ CO2 laser with UVA within-subject pilot RCT (n=10) for patients with stable segmental vitiligo. Median re-pigmentation was 78% for RES™ treated areas, 0% for CO2 control or no treatment areas.

SCAR REVISION: Combination of Medical Needling and ReNovaCell® for Repigmentation of Hypopigmented Burn Scars.

Patients with 1 year old hypopigmented scars treated with RES™ (n=20). The combination of medical needling and RES™ resulted in statistically significant objectively measured repigmentation vs within-subject control scar.

SCAR REVISION: Use of a novel autologous cell-harvesting device to promote epithelialization and enhance appropriate pigmentation in scar reconstruction.

RES™ treatment of post-traumatic scars (n=30) resulted in excellent or good aesthetic and functional outcomes (80%) and normal pigmentation (60%) of the patients.


  1. Navarro FA, Stoner ML, Lee HB, Park CS, Wood FM, Orgill DP. Melanocyte repopulation in full-thickness wounds using a cell spray apparatus. Journal of Burn Care and Research 2000; 22(1):41-46.
  2. Komen L, Vrijman C, Tjin EPM, Krebbers G, de Rie MA, Luiten RM, van der Veen JPW, Wolkerstorfer A. Autologous cell suspension transplantation using a cell harvesting device in segmental vitiligo and piebaldism patients: a randomized controlled pilot study. J Am Acad Dermatol 2015; 73(1):170-172.
  3. Wood FM, Giles N, Stevenson A, Rea S, Fear M. Characterisation of the cell suspension harvested from the dermal epidermal junction using a ReNovaCell® kit. Burns 2012; 38:44-51.
  4. Goodman, G.J. An automated autologous cell transplantation method for the treatment of hypopigmented scarring. Dermatologic Surgery. 2008; 34(4):578-581.
  5. Cervelli, V., DeAngelis, B., Balzani, A., Colicchia, G., Spallone, D., Grimaldi, M. Treatment of stable vitiligo by ReNovaCell® system. Journal of Wound Technology 2009; 17(4), 273-278.
  6. Cervelli V, De Angelis B, Spallone D, Lucarini L, Arpino A, Balzani A. Use of a novel autologous cell-harvesting device to promote epithelialization and enhance appropriate pigmentation in scar
    reconstruction. Clinical and Experimental Dermatology 2009; 35(7): 776-780.
  7. Gramlich G.E.M. Laser Rejuvenation in combination with autologous cell suspension. Kosmetische Medizin 2010; 1(10), 25-29.
  8. Cervelli, V., Spallone, D., Lucarini, L., Palla, L., Brinci, L., DeAngelis, B. (2010). Treatment of stable vitiligo hands by ReNovaCell® system: a preliminary report. European Review for Medical and
    Pharmacological Sciences. 14, 691-694.
  9. Mulekar SV, Ghwish B, Al Issa A, Al Eisa A. Treatment of vitiligo lesions by ReNovaCell® vs conventional melanocyte-keratinocyte transplantation: a pilot study. British Journal of Dermatology 2008; 158(1):45-49.
  10. Busch KH, Bender R, Altintas MA, Pech T, Rohn T, Walezko N, Aust MC. Combination of medicalneedling  and ReNovaCell® for repigmentation of hypopigmented burn scars. Journal of Pigmentary Disorders 2014; 1(3).